PhillipCapital

Investing strategies

The future of weight management: Innovations in weight loss drugs

Beyond the significant health implications, these innovations open substantial investment opportunities.

Broker's Calls

PhillipCapital initiates ‘buy’ on Oiltek International with TP of 70 cents

Analyst Paul Chew likes Oiltek's 'enviable' business, which has a 31% ROE, an asset-light model and strong net cash position.

Broker's Calls

CGSI stays ‘neutral’ on Singapore banks although steeper-than-expected rate cuts may see sequential drop in earnings

PhillipCapital remains “overweight” on the sector as Singapore interest rates inch up.
PhillipCapital lifts TP on Valuetronics to 76 cents after better-than-expected FY2024 patmi - THE EDGE SINGAPORE

Broker's Calls

PhillipCapital lifts TP on Valuetronics to 76 cents after better-than-expected FY2024 patmi

PhillipCapital's Paul Chew has kept his 'buy' call on Valuetronics at a raised target price of 76 cents from 70 cents previously.
Remedying the symptoms of ‘money dysmorphia’ - THE EDGE SINGAPORE

Financially Savvy

Remedying the symptoms of ‘money dysmorphia’

Alvin Tan, financial services director at PhillipCapital, describes the growing phenomenon of “money dysmorphia” among the young.

Broker's Calls

PhillipCapital positive on LHN as co-living profits tripled, more growth expected

LHN is reaping the rewards from the co-living boom.

Broker's Calls

PhillipCapital keeps ‘buy’ on CDL despite higher gearing and lower interest cover

The analyst continues to view CDL as a proxy for the Singapore residential market and hospitality recovery.

Broker's Calls

PhillipCapital downgrades Prime US REIT to ‘accumulate’ as it prices in refinancing risk

Analyst Darren Chan has lowered his target price to 12 US cents.
×